VERINNOGEN LIMITED

CB25 9AU (East of England)

Start Date End Date Funded Value Relevance

CSV

25 50 100

£217,916

Mar 23 - Jun 24

Development and testing of a novel precision tumour measurement device intended for pre-clinical research sector to reduce the consumption of animal models

Innovate UK award to VERINNOGEN LIMITED and Mike Irvine

{{facetGroup.name}}

{{getFilterText(facet,showCount)}}